Statistics from Altmetric.com
Felty syndrome is characterised by chronic arthritis, splenomegaly and leucopenia. Although anaemia is present in many affected patients, significant haemolysis has not yet been described. While disease-modifying agents do not seem to improve leucopenia and anaemia, splenectomy results in a prompt relief of the haematological manifestations in most cases.1–3 To date, rituximab has been used in the treatment of three patients with Felty syndrome, and the haematological manifestation was improved in one patient only.4 5
We report on an improvement of both arthritis and haemolysis, but not of neutropenia and thrombocytopenia, …
Competing interests: None.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.